{"altmetric_id":21719369,"counts":{"readers":{"mendeley":2,"citeulike":1,"connotea":0},"total":{"posts_count":1},"policy":{"unique_users_count":1,"unique_users":["nice"],"posts_count":1}},"citation":{"altmetric_jid":"4f6fa50c3cf058f610003194","authors":["Thomas Walter","Monika K. Krzyzanowska"],"doi":"10.1159\/000337662","first_seen_on":"2017-07-10T12:00:22+00:00","issns":["1423-0194","0028-3835"],"journal":"Neuroendocrinology","last_mentioned_on":1493986272,"links":["http:\/\/dx.doi.org\/10.1159\/000337662"],"pdf_url":"http:\/\/www.karger.com\/Article\/Pdf\/337662","pmid":"22414794","pubdate":"2012-01-01T00:00:00+00:00","publisher":"Karger Publishers","publisher_subjects":[{"name":"Clinical Sciences","scheme":"era"},{"name":"Neurosciences","scheme":"era"}],"scopus_subjects":["Life Sciences","Medicine","Health Sciences","Neuroscience","Biochemistry, Genetics and Molecular Biology"],"subjects":["endocrinology","neurology"],"title":"Quality of Clinical Trials in Gastroenteropancreatic Neuroendocrine Tumours","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/quality-clinical-trials-gastroenteropancreatic-neuroendocrine-tumours"},"altmetric_score":{"score":3,"score_history":{"1y":3,"6m":3,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":3},"context_for_score":{"all":{"total_number_of_other_articles":8160820,"mean":6.9113685834654,"rank":2062839,"this_scored_higher_than_pct":61,"this_scored_higher_than":4981074,"rank_type":"exact","sample_size":8160820,"percentile":61},"similar_age_3m":{"total_number_of_other_articles":164641,"mean":11.300456741983,"rank":51932,"this_scored_higher_than_pct":67,"this_scored_higher_than":111128,"rank_type":"exact","sample_size":164641,"percentile":67},"this_journal":{"total_number_of_other_articles":315,"mean":2.2036305732484,"rank":37,"this_scored_higher_than_pct":60,"this_scored_higher_than":192,"rank_type":"exact","sample_size":315,"percentile":60},"similar_age_this_journal_3m":{"total_number_of_other_articles":3,"mean":0.25,"rank":1,"this_scored_higher_than_pct":66,"this_scored_higher_than":2,"rank_type":"exact","sample_size":3,"percentile":66}}},"demographics":{"users":{"mendeley":{"by_status":{"Researcher":1,"Student  > Ph. D. Student":1},"by_discipline":{"Medicine and Dentistry":2}}},"geo":{"mendeley":{"IT":1}}},"posts":{"policy":[{"title":"Everolimus and sunitinib for treating unresectable or metastatic neuroendocrine tumours in people with progressive disease: Committee papers","url":"https:\/\/www.nice.org.uk\/guidance\/ta449\/documents\/committee-papers","license":"public","citation_ids":[21719232,4323582,21719241,1686227,210723,3261360,2072138,15015188,4481773,185091,4881576,185090,2955948,21719255,21719262,21719267,469143,3760948,4543729,1388591,21719274,1631594,21719277,2414612,6155710,4039888,9683320,14978118,6235398,4301468,1209654,1324014,6005025,22918193,3555764,15781629,658423,21719313,21719317,2412976,1793033,1587282,21719322,2540962,5066855,4399764,21719325,21719328,4794675,1212900,4213785,21719335,2750577,525442,16018645,21719337,2470187,21719344,2054552,213175,16018637,2189646,4138276,4806523,4138278,7590960,21719366,11969334,4042729,4481774,16862636,21719369,21719372,1978380,20584352,21719378,21719379,21719384,1201707,1405028,21719396,6284726,21719398,21719401,19658265,21719405,13193624,10950926,3322234,4150556],"posted_on":"2017-05-05T12:11:12+00:00","source":{"name":"National Institute for Health and Care Excellence","description":"The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.","geo":{"country":"GB"}},"page_url":"https:\/\/www.nice.org.uk\/guidance\/ta449\/evidence","collections":[],"author":{"image":"https:\/\/s3.amazonaws.com\/cache.altmetric.com\/policy\/thumbnails\/thumbnail-5dd3598af8821e9796e733d194eca7a04ccb6ee33da049ae0bb78759a5007c19.jpg"}}]}}